Also trades as: 0JDM.L (LSE) · $vol 0M

$167.90

-0.12 (-0.07%)

Weekly Expected Move ±7.1%

$145 $157 $169 $181 $193

NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Sell · Power 46 · $28.0B mcap · 159M float · 1.12% daily turnover · Short 52% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE

48.8 / 100

NoneWeakNarrowWide

Primary source: Cost Advantage · ROIC: 9.5% · 5Y Avg: 7.5%

Cost Advantage ★

Intangibles

Switching Cost

Network Effect

Scale

The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IQV shows a Weak competitive edge (48.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Cost Advantage. ROIC of 9.5% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets

$225

Low

$225

Avg Target

$225

High

Based on 1 analyst since May 5, 2026 earnings

Analyst Recommendations

Strong Buy: 1Buy: 36Hold: 6Sell: 1Strong Sell: 0

Rating Summary

ConsensusBuy

Avg Target$208.33

Analysts3

Price Target Change History

Date	Firm	Analyst	Old	New	Change	Upside @ Call	Stock@Call
2026-05-07	Morgan Stanley	—	$240	$225	-15	+25.5%	$179.31
2026-04-08	Evercore ISI	Elizabeth Anderson	$225	$185	-40	+7.2%	$172.54
2026-02-23	Mizuho Securities	—	$266	$215	-51	+29.8%	$165.62
2026-02-19	Truist Financial	—	$290	$245	-45	+47.9%	$165.64
2026-02-11	Morgan Stanley	—	$265	$240	-25	+34.2%	$178.88
2026-02-06	UBS	—	$280	$240	-40	+30.4%	$184.01
2026-02-06	BMO Capital	—	Initiated	$250	—	+35.3%	$184.75
2026-02-06	Stifel Nicolaus	—	$254	$220	-34	+19.1%	$184.67
2026-02-06	Barclays	Luke Sergott	$230	$210	-20	+16.0%	$180.96
2026-02-05	Evercore ISI	Elizabeth Anderson	$240	$225	-15	+24.3%	$180.96
2026-01-09	Mizuho Securities	—	$225	$266	+41	+9.4%	$243.19
2026-01-08	UBS	Dan Leonard	$250	$280	+30	+15.4%	$242.66
2026-01-08	Truist Financial	Jailendra Singh	$265	$290	+25	+20.3%	$241.10
2025-12-15	Barclays	—	$200	$230	+30	+3.5%	$222.26
2025-12-01	Morgan Stanley	—	Initiated	$265	—	+16.0%	$228.47
2025-10-29	Stifel Nicolaus	—	$175	$254	+79	+15.6%	$219.81
2025-10-29	UBS	Dan Leonard	Initiated	$250	—	+13.8%	$219.64
2025-10-29	Robert W. Baird	Eric Coldwell	$256	$258	+2	+18.3%	$218.13
2025-10-09	HSBC	—	$160	$235	+75	+17.1%	$200.60
2025-10-08	Evercore ISI	—	$235	$240	+5	+19.5%	$200.86
2025-10-02	Barclays	Luke Sergott	$165	$200	+35	-1.9%	$203.79
2025-09-03	Redburn Partners	Jamie Clark	$188	$214	+26	+17.9%	$181.58
2025-07-25	Mizuho Securities	Ann Hynes	$190	$225	+35	+13.0%	$199.17
2025-05-23	Redburn Partners	Jamie Clark	$276	$188	-88	+37.2%	$137.00
2025-05-15	Mizuho Securities	Ann Hynes	Initiated	$190	—	+35.3%	$140.43
2025-05-07	Barclays	Luke Sergott	$275	$165	-110	+12.9%	$146.20
2025-04-25	HSBC	Sidharth Sahoo	Initiated	$160	—	+6.5%	$150.28
2024-11-04	Truist Financial	Jaliendra Singh	$300	$265	-35	+26.1%	$210.19
2024-10-31	Evercore ISI	Elizabeth Anderson	$270	$235	-35	+14.2%	$205.82
2024-10-29	RBC Capital	Sean Dodge	Initiated	$270	—	+24.1%	$217.54
2024-10-16	Deutsche Bank	Justin Bowers	$275	$270	-5	+15.9%	$232.98
2024-10-14	Redburn Partners	Jamie Clark	Initiated	$276	—	+20.4%	$229.26
2024-09-20	Robert W. Baird	Eric Coldwell	$241	$256	+15	+4.7%	$244.62
2024-08-05	Stifel Nicolaus	Jonathan Block	Initiated	$175	—	-25.8%	$236.24
2024-07-23	Truist Financial	Jailendra Singh	Initiated	$300	—	+24.9%	$240.26
2024-07-23	Evercore ISI	Elizabeth Anderson	$275	$270	-5	+12.7%	$239.50
2024-07-23	Barclays	Luke Sergott	Initiated	$275	—	+12.1%	$245.23
2024-06-18	Deutsche Bank	Justin Bowers	Initiated	$275	—	+29.2%	$212.83
2024-06-13	Robert W. Baird	Eric Coldwell	Initiated	$241	—	+10.8%	$217.46
2024-06-06	Goldman Sachs	Matthew Sykes	Initiated	$270	—	+23.3%	$218.90
2022-08-02	Evercore ISI	Elizabeth Anderson	$320	$275	-45	+16.4%	$236.28
2022-05-12	Piper Sandler	Jeff Garro	Initiated	$255	—	+25.9%	$202.53
2022-04-25	Wells Fargo	—	$300	$235	-65	+3.0%	$228.16
2021-11-18	Evercore ISI	Elizabeth Anderson CFA	Initiated	$320	—	+19.3%	$268.17
2021-11-16	Bank of America Securities	Derik De Bruin	Initiated	$320	—	+21.0%	$264.45
2021-11-16	KeyBanc	Donald Hooker	Initiated	$290	—	+9.7%	$264.45
2021-11-16	Citigroup	Patrick B Donnelly	Initiated	$320	—	+21.0%	$264.45
2021-10-21	Wells Fargo	Dan Leonard	Initiated	$300	—	+16.8%	$256.89
2021-09-09	Argus Research	Jasper Hellweg	Initiated	$290	—	+11.3%	$260.50
2021-08-03	Credit Suisse	Katie Tryhane	Initiated	$272	—	+8.9%	$249.86

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+

May 22, 2026

DCF

ROE

ROA

D/E

P/E

P/B

The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IQV receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (5/5), ROA (4/5). Areas of concern: D/E (2/5), P/E (2/5), P/B (2/5).

Rating Change History

Date	From	To
2026-05-11	A-	B+
2026-05-05	B	A-
2026-04-27	B+	B
2026-04-01	B	B+
2026-02-06	B+	B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 55 Grade C

Profitability

Balance Sheet

Earnings Quality

Growth

Value

Momentum

Safety

Cash Flow

The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IQV scores highest in Momentum (77/100) and lowest in Balance Sheet (23/100). A grade of C represents mixed fundamentals — strengths in some areas offset by weaknesses.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score

1.82

Grey Zone

Piotroski F-Score

6/9

✓ ✓ ✗ ✓ ✓ ✗ ✓ ✗ ✓

Beneish M-Score

-2.56

Unlikely Manipulator

Ohlson O-Score

-6.57

Bankruptcy prob: 0.1%

Low Risk

Credit Rating

BB+

Score: 46.3/100

Trend: Stable

Earnings Quality

100/100

OCF/NI: 1.95x

Accruals: -4.6%

The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IQV scores 1.82, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IQV scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IQV's score of -2.56 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IQV's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IQV receives an estimated rating of BB+ (score: 46.3/100), with a stable trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). IQV's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E

20.42x

PEG

2.10x

P/S

1.69x

P/B

4.55x

P/FCF

10.84x

P/OCF

10.71x

EV/EBITDA

12.24x

EV/Revenue

2.58x

EV/EBIT

18.33x

EV/FCF

16.09x

Earnings Yield

4.78%

FCF Yield

9.23%

Shareholder Yield

1.34%

Graham Number

$83.84

Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 20.4x earnings, IQV commands a growth premium. Graham's intrinsic value formula yields $83.84 per share, 100% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden

0.849

NI / EBT

Interest Burden

0.695

EBT / EBIT

EBIT Margin

0.141

EBIT / Rev

Asset Turnover

0.585

Rev / Assets

Equity Multiplier

4.522

Assets / Equity

ROE

22.0%

The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IQV's ROE of 22.0% is driven by financial leverage (equity multiplier: 4.52x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate

13.40%

Fair P/E

35.29x

Intrinsic Value

$287.88

Price/Value

0.59x

Margin of Safety

40.76%

Premium

-40.76%

Assessment

Undervalued

Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with IQV's realized 13.4% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $287.88, IQV appears undervalued with a 41% margin of safety. The adjusted fair P/E of 35.3x compares to the current market P/E of 20.4x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price

$167.89

Median 1Y

$162.48

5th Pctile

$91.89

95th Pctile

$286.62

Ann. Volatility

34.5%

Analyst Target

$208.33

25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

Executive	Salary	Stock	Total
Ari Bousbib Chairman and Chief Executive Officer	$1,800,000	$15,749,957	$28,128,245
Ronald E. Bruehlman Executive Vice President, Chief Financial Officer	$905,000	$6,749,807	$11,444,200
Alistair R. Grenfell President, Commercial Solutions	$629,907	$5,999,964	$9,704,506
W. Richard Staub, III President, Research & Development Solutions	$800,000	$5,249,918	$8,828,979
Alistair R. Grenfell President, Commercial Solutions Eric M. Sherbet Executive Vice President, General Counsel and Secretary	$665,000	$2,999,982	$5,500,798

CEO Pay Ratio

1309:1

CEO-to-Employee Pay Ratio

CEO Total Comp: $28,128,245

Avg Employee Cost (SGA/emp): $21,495

Employees: 93,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees

93,000

+5.7% YoY

Revenue / Employee

$175,376

Rev: $16,310,000,000

Profit / Employee

$14,624

NI: $1,360,000,000

SGA / Employee

$21,495

Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
ROE	10.1%	12.8%	16.0%	17.9%	19.3%	19.6%	18.5%	17.9%	18.6%	18.9%	22.9%	22.9%	24.0%	23.7%	22.5%	21.9%	20.3%	21.1%	21.6%	22.0%	22.04%
ROA	2.5%	3.2%	3.9%	4.4%	4.7%	4.8%	4.4%	4.2%	4.4%	4.5%	5.2%	5.2%	5.5%	5.4%	5.1%	5.0%	4.6%	4.8%	4.8%	4.9%	4.87%
ROIC	5.2%	5.9%	7.1%	7.8%	8.6%	9.1%	8.4%	8.2%	8.5%	8.7%	9.9%	10.3%	10.5%	10.7%	10.0%	9.8%	9.6%	9.6%	9.4%	9.5%	9.50%
ROCE	5.8%	6.6%	7.7%	8.3%	8.9%	9.4%	9.0%	9.1%	9.7%	10.0%	10.6%	10.6%	10.9%	10.9%	11.8%	11.7%	11.2%	11.6%	10.7%	10.9%	10.86%
Gross Margin	32.5%	33.6%	35.0%	34.9%	26.8%	34.8%	35.6%	34.3%	34.5%	35.1%	35.9%	34.6%	27.7%	35.4%	34.8%	33.9%	32.9%	33.5%	6.7%	32.6%	32.64%
Operating Margin	8.4%	8.9%	12.9%	13.9%	13.2%	13.3%	10.1%	12.9%	14.1%	12.9%	13.0%	13.5%	14.4%	14.1%	15.8%	13.0%	12.6%	13.5%	16.8%	12.4%	12.38%
Net Margin	5.1%	7.7%	8.7%	9.1%	7.2%	7.9%	6.1%	7.9%	8.0%	8.1%	12.1%	7.7%	9.5%	7.3%	11.0%	6.5%	6.6%	8.1%	11.8%	6.6%	6.60%
EBITDA Margin	19.0%	20.7%	19.8%	20.8%	19.3%	20.1%	20.3%	20.7%	21.5%	22.1%	22.5%	20.6%	23.2%	20.5%	25.7%	19.7%	19.4%	21.5%	24.0%	19.3%	19.32%
FCF Margin	16.3%	17.5%	16.6%	13.6%	11.9%	11.9%	11.0%	10.4%	10.8%	8.9%	10.0%	10.8%	12.1%	12.8%	13.7%	14.0%	12.8%	16.6%	15.2%	16.1%	16.07%
OCF Margin	21.1%	22.2%	21.2%	18.4%	16.8%	16.7%	15.7%	15.0%	15.3%	13.2%	14.3%	15.0%	16.1%	16.8%	17.6%	17.8%	16.7%	17.6%	16.3%	16.3%	16.26%
ROE 3Y Avg	snapshot only																				21.83%
ROE 5Y Avg	snapshot only																				20.33%
ROA 3Y Avg	snapshot only																				4.89%
ROIC 3Y Avg	snapshot only																				7.52%
ROIC Economic	snapshot only																				8.73%
Cash ROA	snapshot only																				9.03%
Cash ROIC	snapshot only																				13.17%
CROIC	snapshot only																				13.01%
NOPAT Margin	snapshot only																				11.73%
Pretax Margin	snapshot only																				9.81%
R&D / Revenue	snapshot only																				0.00%
SGA / Revenue	snapshot only																				11.98%
SBC / Revenue	snapshot only																				1.08%

Valuation

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
P/E Ratio	77.81	60.99	56.90	41.44	35.75	29.03	35.42	35.56	38.29	32.70	31.40	34.35	27.38	31.07	25.88	23.44	22.07	25.42	28.49	20.91	20.423
P/S Ratio	3.65	3.46	3.96	3.19	2.93	2.40	2.68	2.59	2.86	2.46	2.85	3.09	2.57	2.85	2.31	2.02	1.74	2.05	2.38	1.74	1.686
P/B Ratio	7.87	7.80	9.10	7.40	6.86	5.68	6.70	6.51	7.28	6.33	6.98	7.63	6.38	7.14	5.86	5.16	4.50	5.38	5.96	4.45	4.547
P/FCF	22.46	19.76	23.88	23.35	24.55	20.12	24.36	24.87	26.53	27.63	28.43	28.70	21.33	22.26	16.81	14.46	13.58	12.35	15.62	10.84	10.837
P/OCF	17.30	15.59	18.68	17.31	17.47	14.34	17.10	17.29	18.72	18.60	19.84	20.68	15.97	16.93	13.08	11.32	10.43	11.63	14.60	10.71	10.709
EV/EBITDA	23.35	21.61	23.93	19.76	18.41	15.81	17.35	16.87	17.68	15.32	16.91	18.05	15.33	16.88	13.80	12.63	11.83	13.08	15.24	12.24	12.238
EV/Revenue	4.50	4.27	4.75	3.97	3.71	3.16	3.49	3.39	3.66	3.24	3.67	3.92	3.39	3.66	3.11	2.81	2.52	2.82	3.24	2.58	2.585
EV/EBIT	49.98	43.51	44.21	34.35	30.39	24.76	28.41	27.51	27.98	24.34	25.83	27.65	23.31	25.56	20.32	18.66	17.79	19.49	22.75	18.33	18.325
EV/FCF	27.69	24.40	28.64	29.07	31.04	26.55	31.74	32.63	33.92	36.49	36.70	36.33	28.12	28.58	22.63	20.15	19.71	17.02	21.28	16.09	16.089
Earnings Yield	1.3%	1.6%	1.8%	2.4%	2.8%	3.4%	2.8%	2.8%	2.6%	3.1%	3.2%	2.9%	3.7%	3.2%	3.9%	4.3%	4.5%	3.9%	3.5%	4.8%	4.78%
FCF Yield	4.5%	5.1%	4.2%	4.3%	4.1%	5.0%	4.1%	4.0%	3.8%	3.6%	3.5%	3.5%	4.7%	4.5%	6.0%	6.9%	7.4%	8.1%	6.4%	9.2%	9.23%
PEG Ratio	snapshot only																				2.105
EV/OCF	snapshot only																				15.899
EV/Gross Profit	snapshot only																				9.899
Acquirers Multiple	snapshot only																				18.651
Shareholder Yield	snapshot only																				1.34%
Graham Number	snapshot only																				$83.84

Leverage & Solvency

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Current Ratio	1.12	1.12	0.91	0.91	0.91	0.91	0.89	0.89	0.89	0.89	0.86	0.86	0.86	0.86	0.84	0.84	0.84	0.84	0.75	0.75	0.749
Quick Ratio	1.12	1.12	0.91	0.91	0.91	0.91	0.89	0.89	0.89	0.89	0.86	0.86	0.86	0.86	0.84	0.84	0.84	0.84	0.75	0.75	0.749
Debt/Equity	2.15	2.15	2.06	2.06	2.06	2.06	2.26	2.26	2.26	2.26	2.27	2.27	2.27	2.27	2.33	2.33	2.33	2.33	2.49	2.49	2.487
Net Debt/Equity	1.83	1.83	1.81	1.81	1.81	1.81	2.03	2.03	2.03	2.03	2.03	2.03	2.03	2.03	2.03	2.03	2.03	2.03	2.16	2.16	2.158
Debt/Assets	0.53	0.53	0.50	0.50	0.50	0.50	0.51	0.51	0.51	0.51	0.52	0.52	0.52	0.52	0.53	0.53	0.53	0.53	0.54	0.54	0.540
Debt/EBITDA	5.17	4.83	4.51	4.42	4.37	4.34	4.48	4.46	4.29	4.14	4.27	4.25	4.15	4.19	4.08	4.10	4.23	4.12	4.67	4.60	4.604
Net Debt/EBITDA	4.41	4.11	3.98	3.89	3.85	3.83	4.03	4.01	3.86	3.72	3.81	3.79	3.70	3.73	3.55	3.57	3.68	3.58	4.05	3.99	3.995
Interest Coverage	2.95	3.43	3.98	4.48	4.77	4.84	4.26	3.80	3.51	3.20	3.17	3.06	3.19	3.23	3.51	3.49	3.24	3.26	3.18	3.10	3.103
Equity Multiplier	4.09	4.09	4.09	4.09	4.09	4.09	4.39	4.39	4.39	4.39	4.37	4.37	4.37	4.37	4.43	4.43	4.43	4.43	4.60	4.60	4.605
Cash Ratio	snapshot only																				0.257
Debt Service Coverage	snapshot only																				4.647
Cash to Debt	snapshot only																				0.132
FCF to Debt	snapshot only																				0.165
Defensive Interval	snapshot only																				997.2 days

Efficiency & Turnover

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Asset Turnover	0.54	0.57	0.56	0.57	0.57	0.58	0.58	0.58	0.59	0.59	0.58	0.58	0.58	0.59	0.58	0.58	0.59	0.59	0.57	0.59	0.585
Inventory Turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Receivables Turnover	5.18	5.42	5.59	5.66	5.70	5.77	5.27	5.31	5.37	5.43	4.76	4.79	4.81	4.86	4.68	4.71	4.77	4.83	4.94	5.04	5.037
Payables Turnover	5.55	5.84	15.36	15.41	15.88	15.99	15.25	15.37	15.12	15.28	14.39	14.46	14.93	15.06	14.25	14.38	14.29	14.58	5.36	5.48	5.478
DSO	70	67	65	65	64	63	69	69	68	67	77	76	76	75	78	78	77	76	74	72	72.5 days
DIO	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.0 days
DPO	66	62	24	24	23	23	24	24	24	24	25	25	24	24	26	25	26	25	68	67	66.6 days
Cash Conversion Cycle	5	5	42	41	41	40	45	45	44	43	51	51	51	51	52	52	51	51	6	6	5.8 days
Fixed Asset Turnover	snapshot only																				20.209
Cash Velocity	snapshot only																				7.768
Capital Intensity	snapshot only																				1.800

Growth (YoY)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue	18.1%	23.5%	22.1%	16.8%	9.4%	5.8%	4.0%	3.4%	3.8%	3.8%	3.9%	3.9%	3.2%	3.1%	2.8%	2.8%	3.6%	3.8%	5.9%	7.3%	7.32%
Net Income	3.6%	3.4%	2.5%	1.6%	91.1%	54.1%	12.9%	-2.2%	-5.5%	-5.6%	24.5%	28.6%	29.8%	25.9%	1.1%	-1.7%	-13.1%	-8.7%	-0.9%	3.8%	3.82%
EPS	3.5%	3.3%	2.4%	1.7%	94.9%	58.9%	16.7%	0.3%	-3.3%	-3.6%	27.4%	31.6%	31.5%	26.8%	3.1%	2.1%	-7.5%	-2.0%	4.2%	8.5%	8.47%
FCF	1.1%	94.9%	71.4%	-6.1%	-19.7%	-28.0%	-31.1%	-21.3%	-6.3%	-22.5%	-5.4%	7.7%	15.5%	48.4%	40.9%	33.2%	10.0%	34.6%	17.3%	23.5%	23.53%
EBITDA	30.2%	36.8%	32.7%	26.3%	14.2%	7.1%	5.3%	3.5%	6.6%	9.9%	12.2%	12.1%	10.4%	5.5%	6.5%	5.5%	-0.0%	3.5%	-0.1%	1.8%	1.80%
Op. Income	66.3%	94.7%	86.7%	72.7%	56.7%	55.9%	29.6%	15.3%	6.5%	-2.5%	9.0%	12.4%	10.3%	13.5%	12.8%	10.3%	7.0%	3.6%	2.6%	3.8%	3.83%
OCF Growth	snapshot only																				-2.10%
Asset Growth	snapshot only																				11.32%
Equity Growth	snapshot only																				7.19%
Debt Growth	snapshot only																				14.26%
Shares Change	snapshot only																				-4.28%

Growth (CAGR)

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue 3Y	8.3%	9.5%	10.0%	10.0%	9.7%	9.6%	9.1%	9.1%	10.3%	10.7%	9.7%	7.8%	5.4%	4.2%	3.6%	3.4%	3.5%	3.6%	4.2%	4.7%	4.67%
Revenue 5Y	16.6%	17.4%	15.1%	12.6%	10.6%	8.5%	8.1%	7.8%	7.6%	7.6%	7.6%	7.4%	7.2%	7.1%	6.8%	6.8%	7.5%	7.7%	7.5%	6.7%	6.72%
EPS 3Y	-20.4%	-13.8%	57.5%	65.6%	70.2%	72.0%	81.4%	72.0%	1.0%	88.2%	71.6%	52.0%	35.3%	24.8%	15.3%	10.5%	5.6%	6.2%	11.0%	13.4%	13.40%
EPS 5Y	-1.5%	3.7%	59.4%	74.1%	87.6%	97.1%	-1.0%	-1.7%	-1.0%	-0.3%	42.2%	43.0%	44.4%	44.1%	50.9%	46.9%	59.5%	52.6%	40.2%	31.2%	31.20%
Net Income 3Y	-22.3%	-15.4%	55.1%	63.3%	67.5%	69.2%	78.8%	69.9%	1.0%	85.1%	69.5%	49.1%	32.8%	22.4%	12.4%	7.3%	2.2%	2.8%	7.6%	9.5%	9.50%
Net Income 5Y	8.2%	14.0%	53.1%	67.4%	82.1%	91.4%	-3.4%	-4.0%	-3.3%	-2.5%	39.3%	40.5%	41.9%	41.9%	48.4%	44.1%	56.4%	48.8%	37.3%	27.6%	27.63%
EBITDA 3Y	10.7%	13.2%	13.5%	13.4%	13.6%	13.0%	13.2%	13.2%	16.6%	17.2%	16.2%	13.6%	10.3%	7.5%	8.0%	7.0%	5.6%	6.3%	6.1%	6.4%	6.39%
EBITDA 5Y	25.1%	26.9%	24.8%	19.9%	16.5%	12.9%	11.2%	10.9%	10.5%	11.3%	11.6%	11.1%	11.5%	10.8%	11.6%	11.4%	11.8%	11.9%	10.8%	9.5%	9.51%
Gross Profit 3Y	6.2%	6.8%	8.2%	8.9%	7.2%	11.0%	11.0%	11.1%	18.7%	14.8%	13.8%	12.2%	5.2%	4.4%	3.2%	2.3%	5.3%	4.5%	-3.5%	-3.1%	-3.13%
Gross Profit 5Y	20.8%	21.2%	16.7%	13.2%	9.4%	7.1%	6.6%	6.2%	7.1%	7.0%	7.4%	7.4%	6.2%	8.3%	7.9%	8.0%	12.0%	9.4%	3.8%	3.0%	3.03%
Op. Income 3Y	13.7%	18.3%	23.6%	26.5%	29.7%	31.4%	31.5%	31.8%	40.5%	43.6%	38.1%	30.8%	22.6%	19.9%	16.8%	12.6%	7.9%	4.6%	8.0%	8.8%	8.79%
Op. Income 5Y	10.4%	12.6%	16.9%	19.8%	22.4%	23.6%	20.3%	19.5%	19.6%	20.3%	21.7%	21.2%	20.7%	20.2%	22.8%	23.2%	26.8%	28.3%	25.0%	20.7%	20.72%
FCF 3Y	39.6%	54.1%	42.5%	41.7%	33.6%	36.7%	23.8%	19.4%	17.3%	2.8%	3.8%	-7.3%	-4.6%	-6.1%	-2.8%	4.1%	6.0%	15.7%	16.1%	21.0%	21.01%
FCF 5Y	31.3%	35.4%	27.0%	26.6%	18.5%	15.5%	21.4%	16.0%	15.4%	15.3%	13.5%	19.3%	20.9%	24.0%	20.4%	19.6%	15.5%	16.8%	13.1%	5.6%	5.56%
OCF 3Y	32.9%	41.0%	32.9%	29.7%	23.3%	24.1%	16.8%	13.9%	13.1%	3.1%	3.1%	-5.4%	-3.7%	-4.9%	-2.6%	2.3%	3.3%	5.4%	5.5%	7.6%	7.63%
OCF 5Y	33.6%	37.1%	27.9%	26.3%	18.7%	15.1%	18.4%	14.6%	14.0%	12.9%	11.4%	13.7%	14.0%	15.6%	13.9%	13.5%	11.1%	9.4%	6.3%	0.3%	0.31%
Assets 3Y	2.6%	2.6%	3.1%	3.1%	3.1%	3.1%	2.9%	2.9%	2.9%	2.9%	2.8%	2.8%	2.8%	2.8%	2.9%	2.9%	2.9%	2.9%	5.7%	5.7%	5.73%
Assets 5Y	44.3%	44.3%	3.1%	3.1%	3.1%	3.1%	2.2%	2.2%	2.2%	2.2%	3.4%	3.4%	3.4%	3.4%	3.0%	3.0%	3.0%	3.0%	4.0%	4.0%	4.04%
Equity 3Y	-9.5%	-9.5%	-3.5%	-3.5%	-3.5%	-3.5%	-1.3%	-1.3%	-1.3%	-1.3%	0.6%	0.6%	0.6%	0.6%	0.1%	0.1%	0.1%	0.1%	4.1%	4.1%	4.10%
Book Value 3Y	-7.3%	-7.8%	-1.9%	-2.1%	-1.9%	-1.8%	0.1%	-0.1%	-0.6%	0.3%	1.9%	2.5%	2.5%	2.6%	2.7%	3.1%	3.5%	3.5%	7.4%	7.8%	7.81%
Dividend 3Y	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Growth Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Revenue Stability	0.92	0.92	0.94	0.97	0.96	0.89	0.91	0.94	0.93	0.91	0.92	0.95	0.97	0.94	0.93	0.92	0.91	0.90	0.94	0.97	0.966
Earnings Stability	0.00	0.02	0.01	0.06	0.11	0.17	0.02	0.03	0.06	0.09	0.88	0.89	0.89	0.89	0.90	0.87	0.77	0.76	0.76	0.74	0.741
Margin Stability	0.88	0.91	0.95	0.95	0.91	0.95	0.95	0.94	0.91	0.95	0.95	0.95	0.97	0.97	0.96	0.96	0.92	0.96	0.90	0.89	0.893
Rev. Growth Consistency	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.00	1.000
Earn. Growth Consistency	0.50	0.50	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	1.00	0.50	0.50	0.50	1.00	0.00	0.00	0.00	0.00	0.50	0.500
FCF Positive Streak	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Earnings Persistence	0.50	0.50	0.50	0.50	0.50	0.50	0.95	0.99	0.98	0.98	0.90	0.89	0.88	0.90	1.00	0.99	0.95	0.97	1.00	0.98	0.985
Earnings Smoothness	0.00	0.00	0.00	0.10	0.37	0.57	0.88	0.98	0.94	0.94	0.78	0.75	0.74	0.77	0.99	0.98	0.86	0.91	0.99	0.96	0.962
ROE Trend	0.07	0.09	0.12	0.13	0.13	0.12	0.09	0.06	0.04	0.03	0.05	0.04	0.04	0.04	0.02	0.02	-0.01	-0.00	-0.02	-0.01	-0.008
Gross Margin Trend	0.02	0.02	0.02	0.03	0.02	0.01	0.01	0.00	0.02	0.02	0.02	0.02	-0.00	-0.00	-0.01	-0.01	0.00	-0.00	-0.08	-0.08	-0.079
FCF Margin Trend	0.08	0.09	0.07	0.01	-0.01	-0.02	-0.03	-0.05	-0.03	-0.06	-0.04	-0.01	0.01	0.02	0.03	0.03	0.01	0.06	0.03	0.04	0.037
Sustainable Growth Rate	10.1%	12.8%	16.0%	17.9%	19.3%	19.6%	18.5%	17.9%	18.6%	18.9%	22.9%	22.9%	24.0%	23.7%	22.5%	21.9%	20.3%	21.1%	21.6%	22.0%	22.04%
Internal Growth Rate	2.6%	3.3%	4.1%	4.6%	4.9%	5.0%	4.6%	4.4%	4.6%	4.7%	5.5%	5.5%	5.8%	5.7%	5.4%	5.2%	4.8%	5.0%	5.0%	5.1%	5.12%

Cash Flow Quality

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
OCF/Net Income	4.50	3.91	3.05	2.39	2.05	2.02	2.07	2.06	2.05	1.76	1.58	1.66	1.71	1.83	1.98	2.07	2.12	2.19	1.95	1.95	1.952
FCF/OCF	0.77	0.79	0.78	0.74	0.71	0.71	0.70	0.70	0.71	0.67	0.70	0.72	0.75	0.76	0.78	0.78	0.77	0.94	0.93	0.99	0.988
FCF/Net Income	snapshot only																				1.929
OCF/EBITDA	snapshot only																				0.770
CapEx/Revenue	4.8%	4.7%	4.6%	4.8%	4.8%	4.8%	4.7%	4.6%	4.5%	4.3%	4.3%	4.2%	4.0%	4.0%	3.9%	3.9%	3.9%	1.0%	1.1%	0.2%	0.19%
CapEx/Depreciation	snapshot only																				0.027
Accruals Ratio	-0.09	-0.09	-0.08	-0.06	-0.05	-0.05	-0.05	-0.04	-0.05	-0.03	-0.03	-0.03	-0.04	-0.05	-0.05	-0.05	-0.05	-0.06	-0.05	-0.05	-0.046
Sloan Accruals	snapshot only																				-0.075
Cash Flow Adequacy	snapshot only																				84.500
Earnings Quality Score	snapshot only																				1.000

Dividends & Buybacks

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Dividend Yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Dividend/Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
FCF Payout Ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.00%
Total Payout Ratio	34.3%	39.5%	42.0%	69.2%	1.0%	1.1%	1.1%	84.7%	81.6%	74.2%	73.0%	63.6%	26.2%	30.5%	98.3%	1.3%	1.9%	89.6%	15.6%	28.1%	28.09%
Div. Increase Streak	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Chowder Number	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Buyback Yield	0.4%	0.6%	0.7%	1.7%	2.9%	3.8%	3.0%	2.4%	2.1%	2.3%	2.3%	1.9%	1.0%	1.0%	3.8%	5.5%	8.7%	3.5%	0.5%	1.3%	1.34%
Net Buyback Yield	0.4%	0.6%	0.7%	1.7%	2.9%	3.8%	3.0%	2.4%	2.1%	2.3%	2.3%	1.9%	1.0%	1.0%	3.8%	5.5%	8.7%	3.5%	0.4%	1.1%	1.11%
Total Shareholder Return	0.4%	0.6%	0.7%	1.7%	2.9%	3.8%	3.0%	2.4%	2.1%	2.3%	2.3%	1.9%	1.0%	1.0%	3.8%	5.5%	8.7%	3.5%	0.4%	1.1%	1.11%

DuPont Factors

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Tax Burden (NI/EBT)	0.78	0.81	0.85	0.85	0.84	0.81	0.81	0.80	0.80	0.82	0.93	0.94	0.95	0.94	0.82	0.81	0.81	0.81	0.84	0.85	0.849
Interest Burden (EBT/EBIT)	0.67	0.72	0.76	0.78	0.80	0.79	0.76	0.74	0.71	0.69	0.68	0.67	0.68	0.68	0.71	0.71	0.69	0.69	0.70	0.70	0.695
EBIT Margin	0.09	0.10	0.11	0.12	0.12	0.13	0.12	0.12	0.13	0.13	0.14	0.14	0.15	0.14	0.15	0.15	0.14	0.14	0.14	0.14	0.141
Asset Turnover	0.54	0.57	0.56	0.57	0.57	0.58	0.58	0.58	0.59	0.59	0.58	0.58	0.58	0.59	0.58	0.58	0.59	0.59	0.57	0.59	0.585
Equity Multiplier	3.98	3.98	4.09	4.09	4.09	4.09	4.24	4.24	4.24	4.24	4.38	4.38	4.38	4.38	4.40	4.40	4.40	4.40	4.52	4.52	4.522

Per Share

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
EPS (Diluted TTM)	$3.11	$3.93	$4.96	$5.58	$6.07	$6.24	$5.78	$5.59	$5.87	$6.02	$7.37	$7.36	$7.72	$7.63	$7.59	$7.52	$7.14	$7.47	$7.91	$8.16	$8.16
Book Value/Share	$30.79	$30.73	$31.02	$31.24	$31.62	$31.90	$30.57	$30.57	$30.88	$31.08	$33.16	$33.16	$33.16	$33.18	$33.56	$34.20	$35.03	$35.33	$37.83	$38.30	$37.70
Tangible Book/Share	$-60.84	$-60.72	$-62.64	$-63.09	$-63.85	$-64.42	$-68.80	$-68.80	$-69.50	$-69.95	$-72.13	$-72.13	$-72.13	$-72.17	$-72.69	$-74.08	$-75.88	$-76.54	$-87.70	$-88.78	$-88.78
Revenue/Share	$66.34	$69.30	$71.21	$72.55	$74.03	$75.60	$76.46	$76.91	$78.63	$80.08	$81.30	$81.76	$82.23	$83.14	$85.20	$87.36	$90.65	$92.63	$94.88	$97.95	$98.76
FCF/Share	$10.79	$12.12	$11.82	$9.90	$8.84	$9.00	$8.41	$8.00	$8.47	$7.12	$8.14	$8.81	$9.91	$10.65	$11.69	$12.19	$11.61	$15.38	$14.43	$15.74	$15.87
OCF/Share	$14.01	$15.36	$15.10	$13.36	$12.42	$12.63	$11.98	$11.50	$12.01	$10.58	$11.66	$12.23	$13.24	$14.00	$15.02	$15.57	$15.11	$16.33	$15.44	$15.92	$16.06
Cash/Share	$9.76	$9.74	$7.58	$7.64	$7.73	$7.80	$6.94	$6.94	$7.01	$7.06	$8.12	$8.12	$8.12	$8.12	$10.19	$10.39	$10.64	$10.73	$12.45	$12.61	$11.56
EBITDA/Share	$12.80	$13.69	$14.14	$14.57	$14.90	$15.12	$15.39	$15.47	$16.26	$16.96	$17.67	$17.74	$18.18	$18.02	$19.18	$19.45	$19.34	$20.01	$20.15	$20.69	$20.69
Debt/Share	$66.21	$66.07	$63.85	$64.31	$65.09	$65.67	$68.99	$68.99	$69.69	$70.14	$75.40	$75.40	$75.40	$75.44	$78.30	$79.80	$81.73	$82.45	$94.09	$95.25	$95.25
Net Debt/Share	$56.45	$56.33	$56.27	$56.68	$57.36	$57.87	$62.05	$62.05	$62.68	$63.08	$67.28	$67.28	$67.28	$67.32	$68.10	$69.41	$71.09	$71.71	$81.63	$82.64	$82.64

Academic Models

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Altman Z-Score	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	1.823
Altman Z-Prime	snapshot only																				2.181
Piotroski F-Score	8	7	7	8	7	8	8	6	7	7	8	8	7	8	7	6	7	6	6	6	6
Beneish M-Score	-3.01	-2.87	-2.80	-2.75	-2.53	-2.66	-2.59	-2.55	-2.67	-2.50	-2.46	-2.49	-2.39	-2.54	-2.71	-2.76	-2.84	-2.75	-0.36	-2.56	-2.560
Ohlson O-Score	snapshot only																				-6.574
Net-Net WC	snapshot only																				$-100.50
EVA	snapshot only																				$-101910852.24

Credit

Metric	Q2'21	Q3'21	Q4'21	Q1'22	Q2'22	Q3'22	Q4'22	Q1'23	Q2'23	Q3'23	Q4'23	Q1'24	Q2'24	Q3'24	Q4'24	Q1'25	Q2'25	Q3'25	Q4'25	Q1'26	Current
Credit Rating	snapshot only																				BB+
Credit Score	40.66	46.42	47.80	44.57	45.28	46.24	47.08	46.81	46.51	46.73	47.61	47.14	47.43	47.31	47.49	47.15	47.55	47.02	45.89	46.33	46.330
Credit Grade	snapshot only																				11
Credit Trend	snapshot only																				-0.822
Implied Spread (bps)	snapshot only																				400.000
Industry Credit Rank	snapshot only																				46
Sector Credit Rank	snapshot only																				39

IQV NYSE

Edge Score

Analyst Insights

Financial Rating

InsiderStreet Scorecard

Risk & Quality Signals

Valuation

DuPont Decomposition (5-Factor)

Graham-Dodd Adjusted Valuation

Profitability Trends

Leverage & Solvency Trends

Efficiency & Working Capital Trends

Growth Trends (YoY %)

Earnings Stability

Monte Carlo Price Simulation

Executive Compensation

C-Suite Compensation

CEO Pay Ratio

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Scaling Efficiency

Sign in to InsiderStreet